Enlitic develops a medical deep learning platform that leverages practicing radiologists, data scientists, and software engineers to analyze large streams of healthcare data. The platform ingests millions of clinical cases from cross-sector healthcare partners to improve diagnostic accuracy and speed. Enlitic positions its technology to improve patient outcomes and to accelerate pharmaceutical research and drug trials. The company operates from offices in San Francisco, New York and Sydney. Leadership includes CEO Kevin Lyman and CMO Anthony Upton. It intends to use new funding to continue building out its AI software platform and to grow its global presence with major regional healthcare partners. Enlitic uses deep learning and other forms of artificial intelligence to develop algorithms that identify and analyze suspicious findings in medical images. The company has built a comprehensive platform that enables development, validation, and integration of clinical AI at scale, working closely with hospitals and radiology providers worldwide. Its first product interprets chest x-rays, triaging normal from abnormal scans and detecting and characterizing more than 40 distinct abnormalities such as cardiomegaly, lung nodules, and pneumothorax. Enlitic plans to use new funding to enhance its AI product portfolio and expand its engineering and data-scientist teams. The company is also focusing on obtaining regulatory approval for clinical use in the US, Australia, Japan, Europe, Canada, and Brazil. Enlitic is led by CEO Kevin Lyman and Chief Medical Officer Dr. Anthony Upton. Enlitic is a San Francisco-based deep learning company dedicated to improving diagnostic healthcare, led by CEO and data scientist Jeremy Howard. Its core product is a suite of deep-learning diagnostic tools commercially integrated end-to-end across a wide range of ailments, from lung cancer to bone fractures. Those tools are deployed to support radiologists’ workflows and are expected to power hundreds of radiologists across Capitol Health’s care network. Enlitic leverages Capitol Health’s image archives across multiple modalities (Ultrasound, CT, MRI, PET, X-Ray) to accelerate training of algorithms and to support diagnosis of thousands of diseases and afflictions. The company plans to expand the platform’s use cases and to map the entire human body and its afflictions. It will use the new funding to advance those efforts and to broaden deployment in partnered markets. Enlitic is a San Francisco, CA-based diagnostic healthcare company that uses machine learning to improve medical diagnostics. The company develops tools for physicians that can ingest and analyze medical images, doctors' notes, and structured lab tests to make diagnoses faster and more accurate. Led by founder and CEO Jeremy Howard, Enlitic aims to make diagnostics more accessible by leveraging advances in machine learning across different data types. Financially, Enlitic raised $2M in a funding round led by Amplify Partners with participation from Data Collective. The company is hiring, indicating growth or product development momentum. The article does not disclose operating metrics such as revenue or user counts.

Total raised

$52M

Funding rounds

4

Latest round

Series B

Latest activity

Nov 2019